BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21800541)

  • 21. Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein.
    Li HQ; Yang J; Ma S; Qiao C
    Bioorg Med Chem; 2012 Jul; 20(14):4194-200. PubMed ID: 22739087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic bioactivity of some phenylpropanoic acid derivatives.
    Reta GF; Tonn CE; Ríos-Luci C; León LG; Pérez-Roth E; Padrón JM; Donadel OJ
    Nat Prod Commun; 2012 Oct; 7(10):1341-6. PubMed ID: 23157005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparations of vitamin D analogs, spirostanols and furostanols from diosgenin and their cytotoxic activities.
    Quan HJ; Koyanagi J; Komada F; Saito S
    Eur J Med Chem; 2005 Jul; 40(7):662-73. PubMed ID: 15935901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
    Doshi JM; Tian D; Xing C
    J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumour and immunomodulating activities of diosgenin, a naturally occurring steroidal saponin.
    He Z; Tian Y; Zhang X; Bing B; Zhang L; Wang H; Zhao W
    Nat Prod Res; 2012; 26(23):2243-6. PubMed ID: 22235932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo anticancer activity of steroid saponins of Paris polyphylla var. yunnanensis.
    Yan LL; Zhang YJ; Gao WY; Man SL; Wang Y
    Exp Oncol; 2009 Mar; 31(1):27-32. PubMed ID: 19300413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis and anti-tumor activity of ursolic acid derivatives].
    Meng YQ; Liu D; Bai ZW; Cai LL; Ai HR
    Yao Xue Xue Bao; 2011 May; 46(5):556-60. PubMed ID: 21800543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis.
    Liu MJ; Wang Z; Ju Y; Wong RN; Wu QY
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):79-90. PubMed ID: 15372201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dioscin sensitizes cells to TRAIL-induced apoptosis through downregulation of c-FLIP and Bcl-2.
    Kim YS; Kim EA; Park KG; Lee SJ; Kim MS; Sohn HY; Lee TJ
    Oncol Rep; 2012 Nov; 28(5):1910-6. PubMed ID: 22895655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function relationship for saponin effects on cell cycle arrest and apoptosis in the human 1547 osteosarcoma cells: a molecular modelling approach of natural molecules structurally close to diosgenin.
    Trouillas P; Corbière C; Liagre B; Duroux JL; Beneytout JL
    Bioorg Med Chem; 2005 Feb; 13(4):1141-9. PubMed ID: 15670922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression.
    Shishodia S; Aggarwal BB
    Oncogene; 2006 Mar; 25(10):1463-73. PubMed ID: 16331273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synthesis of ursolic acid derivatives with cytotoxic activity and the investigation of their preliminary mechanism of action.
    Meng YQ; Liu D; Cai LL; Chen H; Cao B; Wang YZ
    Bioorg Med Chem; 2009 Jan; 17(2):848-54. PubMed ID: 19091579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and cytotoxicities of dioscin derivatives with decorated chacotriosyl residues.
    Zhu S; Zhang Y; Li M; Yu J; Zhang L; Li Y; Yu B
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5629-32. PubMed ID: 16905317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cancer effects of Polyphyllin I: An update in 5 years.
    Tian Y; Gong GY; Ma LL; Wang ZQ; Song D; Fang MY
    Chem Biol Interact; 2020 Jan; 316():108936. PubMed ID: 31870841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis in HepG2 cells by solanine and Bcl-2 protein.
    Ji YB; Gao SY; Ji CF; Zou X
    J Ethnopharmacol; 2008 Jan; 115(2):194-202. PubMed ID: 18022776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
    Hu K; Yao X
    Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21(waf1) and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cells.
    Leal AS; Wang R; Salvador JA; Jing Y
    ChemMedChem; 2012 Sep; 7(9):1635-46. PubMed ID: 22807348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
    Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
    J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in small-molecule inhibitors of Bcl-2 family proteins].
    Tang Y; Zhang DY; Wu XM
    Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.